Global and United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Report & Forecast 2022-2028

Global and United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Introduction
1.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume for the Year 2017-2028
1.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume for the Year 2017-2028
1.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Dynamics
1.5.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Trends
1.5.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers
1.5.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Challenges
1.5.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment by Type
2.1.1 Macular Degeneration Drugs
2.1.2 Diabetic Retinopathy Drugs
2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type
2.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type
2.3.1 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment by Application
3.1.1 50-60 Years Old
3.1.2 60-70 Years Old
3.1.3 Others
3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application
3.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application
3.3.1 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Competitor Landscape by Company
4.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Company
4.1.1 Top Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Manufacturer (2017-2022)
4.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Concentration Ratio (CR)
4.2.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in 2021
4.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Company
4.5.1 Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Players (2020, 2021 & 2022)
5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Region
5.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Corporation Information
7.1.2 Novartis Description and Business Overview
7.1.3 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.1.5 Novartis Recent Development
7.2 Bayer Healthcare
7.2.1 Bayer Healthcare Corporation Information
7.2.2 Bayer Healthcare Description and Business Overview
7.2.3 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.2.5 Bayer Healthcare Recent Development
7.3 Roche
7.3.1 Roche Corporation Information
7.3.2 Roche Description and Business Overview
7.3.3 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.3.5 Roche Recent Development
7.4 Neurotech Pharmaceuticals
7.4.1 Neurotech Pharmaceuticals Corporation Information
7.4.2 Neurotech Pharmaceuticals Description and Business Overview
7.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.4.5 Neurotech Pharmaceuticals Recent Development
7.5 Regeneron Pharmaceuticals
7.5.1 Regeneron Pharmaceuticals Corporation Information
7.5.2 Regeneron Pharmaceuticals Description and Business Overview
7.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.5.5 Regeneron Pharmaceuticals Recent Development
7.6 Allergan
7.6.1 Allergan Corporation Information
7.6.2 Allergan Description and Business Overview
7.6.3 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
7.6.5 Allergan Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Chain Analysis
8.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors
8.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Production Mode & Process
8.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Marketing
8.4.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Channels
8.4.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors
8.5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Trends
Table 3. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers
Table 4. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Challenges
Table 5. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints
Table 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs as of 2021)
Table 18. Top Players of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
Table 20. Date of International Manufacturers Enter into Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Novartis Corporation Information
Table 43. Novartis Description and Business Overview
Table 44. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 46. Novartis Recent Development
Table 47. Bayer Healthcare Corporation Information
Table 48. Bayer Healthcare Description and Business Overview
Table 49. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Bayer Healthcare Product
Table 51. Bayer Healthcare Recent Development
Table 52. Roche Corporation Information
Table 53. Roche Description and Business Overview
Table 54. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Roche Product
Table 56. Roche Recent Development
Table 57. Neurotech Pharmaceuticals Corporation Information
Table 58. Neurotech Pharmaceuticals Description and Business Overview
Table 59. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Neurotech Pharmaceuticals Product
Table 61. Neurotech Pharmaceuticals Recent Development
Table 62. Regeneron Pharmaceuticals Corporation Information
Table 63. Regeneron Pharmaceuticals Description and Business Overview
Table 64. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. Regeneron Pharmaceuticals Product
Table 66. Regeneron Pharmaceuticals Recent Development
Table 67. Allergan Corporation Information
Table 68. Allergan Description and Business Overview
Table 69. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Allergan Product
Table 71. Allergan Recent Development
Table 72. Key Raw Materials Lists
Table 73. Raw Materials Key Suppliers Lists
Table 74. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Customers List
Table 75. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors List
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Picture
Figure 2. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales 2017-2028 (K MT)
Figure 5. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales 2017-2028 (K MT)
Figure 8. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Report Years Considered
Figure 11. Product Picture of Macular Degeneration Drugs
Figure 12. Product Picture of Diabetic Retinopathy Drugs
Figure 13. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Type in 2022 & 2028
Figure 14. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2017-2028) & (K MT)
Figure 17. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2017-2028) & (USD/MT)
Figure 19. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Type in 2022 & 2028
Figure 20. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2017-2028) & (K MT)
Figure 23. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2017-2028) & (USD/MT)
Figure 25. Product Picture of 50-60 Years Old
Figure 26. Product Picture of 60-70 Years Old
Figure 27. Product Picture of Others
Figure 28. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Application in 2022 & 2028
Figure 29. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 31. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2017-2028) & (K MT)
Figure 32. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 33. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2017-2028) & (USD/MT)
Figure 34. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Application in 2022 & 2028
Figure 35. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 36. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 37. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2017-2028) & (K MT)
Figure 38. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 39. United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2017-2028) & (USD/MT)
Figure 40. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 41. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 42. U.S. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 45. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 46. Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. U.K. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Russia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 52. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 53. China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. South Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Australia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Taiwan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Indonesia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Thailand Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Malaysia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Philippines Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 64. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 65. Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
F

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs